Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia and to a lesser extent in mood disorders. To comprehensively examine the ionotropic glutamate receptors in these illnesses, we used in situ hybridization to determine transcript expression of N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and kainate receptor subunits in the medial temporal lobe of subjects with schizophrenia, bipolar disorder (BD), or major depression (MDD). We used receptor autoradiography to assess changes in glutamate receptor binding in the same subjects. Our results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders. We did not find any changes in transcript expression in the hippocampus. In the entorhinal cortex, most changes in glutamate receptor expression were associated with BD, with decreased GluR2, GluR3, and GluR6 mRNA expression. In the perirhinal cortex we detected decreased expression of GluR5 in all three diagnoses, of GluR1, GluR3, NR2B in both BD and MDD, and decreased NR1 and NR2A in BD and MDD, respectively. Receptor binding showed NMDA receptor subsites particularly affected in the hippocampus, where MK801 binding was reduced in schiz…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In depressed patients, synaptic plasticity pathways have been shown to be disrupted in the PFC and hippocampi, correlated with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptor abnormalities [45,46].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [45]
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 2×
“Neurotransmission mediated by ionotropic glutamate receptors underlies several forms of synaptic plasticity in the hippocampus, including long-term potentiation (LTP) and depression (LTD) (Bliss and Collingridge, 1993; Isaac et al, 1995; Linden and Connor, 1995; Nicoll and Malenka, 1995; Selig et al, 1995; Bear and Ab…”
BackgroundLOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS
Scoville, W. B., & Milner, B. (1957) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.20.1.11 · Cited by 7,322
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 2×
“Scale bar: 5 mm. Neuropsychopharmacology containing predominantly NR2B to containing NR2A in response to different stimuli (Monyer et al, 1994; Sheng et al, 1994).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282 · cited 1×
“The entorhinal cortex is a crucial component of the medial temporal lobe memory system (Scoville and Milner, 1957; Squire and Zola-Morgan, 1991).”
BackgroundLong-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · cited 1×
“…in neuronal size, density, and localization in the hippocampus in schizophrenia and BD, and to a lesser extent in major depressive disorder (MDD) (Arnold, 1997; Benes et al, 1998, 1999; Harrison, 1999; Weinberger, 1999; Harrison and Eastwood, 2001; Heckers and Konradi, 2002; Rajkowska, 2002a, b).”
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
Cited by
Items 201–300 of 451
Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain
Caffino, L., Piva, A., Giannotti, G., Chio, M. D., Mottarlini, F., Vènniro, M., Yew, D. T. W., Chiamulera, C., & Fumagalli, F. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0231-6 · Cited by 31
Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder
Duncan, R. E., & Bazinet, R. P. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328336b615 · Cited by 30
Lou, J.-S., Li, C., Yang, X., Fang, J., Yang, Y., & Guo, J. (2010) · Pharmaceutical Biology · doi:10.3109/13880201003789440 · Cited by 30
Gangwar, S. P., Yen, L. Y., Yelshanskaya, M. V., & Sobolevsky, A. I. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112124 · Cited by 29
Nghia, N. A., Hirasawa, T., Kasai, H., Obata, C., Moriishi, K., Mochizuki, K., Koizumi, S., & Kubota, T. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.010 · Cited by 29
D-Amino Acids as a Biomarker in Schizophrenia
Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., Kitagishi, Y., & Matsuda, S. (2022) · Diseases · doi:10.3390/diseases10010009 · Cited by 29
Kawatake-Kuno, A., Murai, T., & Uchida, S. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.749180 · Cited by 28
Hirata, Y., Zai, C. C. H., de Souza, R. P., Lieberman, J. A., Meltzer, H. Y., & Kennedy, J. L. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2233 · Cited by 28
A Role for Matrix Metalloproteases in Antidepressant Efficacy
Alaiyed, S., & Conant, K. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00117 · Cited by 28
Goldberg‐Stern, H., Ganor, Y., Cohen, R., Pollak, L., Teichberg, V. I., & Levite, M. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.007 · Cited by 28
Lawn, T., Giacomel, A., Martins, D., Veronese, M., Howard, M. A., Turkheimer, F., & Dipasquale, O. (2024) · Communications Biology · doi:10.1038/s42003-024-06391-3 · Cited by 28
Borsoï, M., Antonio, C. B., Müller, L. G., Viana, A. F., Hertzfeldt, V., Lunardi, P. S., Zanotto, C., Nardin, P., Ravazzolo, A. P., Rates, S. M. K., et al. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.012 · Cited by 27
Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability
Dimassi, S., Andrieux, J., Labalme, A., Lesca, G., Cordier, M., Boute, O., Neut, D., Edery, P., Sanlaville, D., & Schluth‐Bolard, C. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36079 · Cited by 27
Glutamate hypothesis of depression and its consequences for antidepressant treatments
Musazzi, L., Treccani, G., & Popoli, M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.96 · Cited by 27
Suzuki, A., Murakami, K., Tajima, Y., Hara, H., Kunugi, A., & Kimura, H. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.06.004 · Cited by 26
Sun, X., Pinacho, R., Saia, G., Punko, D., Meana, J. J., Ramos, B., & Gill, G. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22212 · Cited by 26
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
Beck, K., Arumuham, A., Veronese, M., Santangelo, B., McGinnity, C. J., Dunn, J., McCutcheon, R. A., Kaar, S. J., Singh, N., Pillinger, T., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01540-2 · Cited by 26
Chitty, K. M., Lagopoulos, J., Hickie, I. B., & Hermens, D. F. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.05.002 · Cited by 26
The role of NMDA receptors in bipolar disorder: A systematic review
Weiss, F., Caruso, V., Rosa, U. D., Beatino, M. F., Barbuti, M., Nicoletti, F., & Perugi, G. (2023) · Bipolar Disorders · doi:10.1111/bdi.13335 · Cited by 25
Geng, L., Qian, F., Qian, J.-F., & Zhang, Z. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.01.006 · Cited by 25
Yu, Z., Li, D., Zhai, S., Xu, H., Liu, H., Ao, M., Zhao, C., Jin, W., & Yu, L. (2021) · Food & Function · doi:10.1039/d1fo01720a · Cited by 25
Lazic, S. E. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-5 · Cited by 25
Alushin, G. M., Jane, D. E., & Mayer, M. L. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.06.002 · Cited by 25
Kilonzo, K., Strahnen, D., Prex, V., Gems, J., van der Veen, B., Kapanaiah, S. K. T., Murthy, B. K. B., Schulz, S., Sprengel, R., Bannerman, D. M., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01863-8 · Cited by 24
Nasyrova, R. F., Khasanova, A. K., Altynbekov, K. S., Asadullin, A. R., Markina, E. A., Gayduk, A., Shipulin, G. A., Петрова, М. М., & Shnayder, N. A. (2022) · Nutrients · doi:10.3390/nu14235142 · Cited by 24
Crisafulli, C., Chiesa, A., Ronchi, D. D., Han, C., Lee, S.-J., Park, M. H., Patkar, A. A., Pae, C.-U., & Serretti, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.074 · Cited by 24
Peng, L., Li, B., Du, T., Wang, F., & Hertz, L. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.021 · Cited by 24
Umanah, G. K. E., Pignatelli, M., Yin, X., Chen, R., Crawford, J. A., Neifert, S., Scarffe, L. A., Behensky, A. A., Guiberson, N. G. L., Chang, M. I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4985 · Cited by 24
Jia, W., Zhang, R., Wu, B., Dai, Z., Zhu, Y., Li, P., & Zhu, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087247 · Cited by 24
Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population
Kang, W. S., Park, J. K., Kim, S. K., Park, H., Lee, S. M., Song, J. Y., Chung, J., & Kim, J.-W. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1960-x · Cited by 24
Nations, K. R., Bursi, R., Dogterom, P., Ereshefsky, L., Gertsik, L., Mant, T., & Schipper, J. (2012) · Drugs in R&D · doi:10.1007/bf03262197 · Cited by 23
Behavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 23
Kang, J., Wang, D., Duan, Y., Zhai, L., Shi, L. S., & Guo, F. (2020) · Brain Sciences · doi:10.3390/brainsci11010009 · Cited by 23
Losing balance: Kainate receptors and psychiatric disorders comorbidities
Valbuena, S., & Lerma, J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108558 · Cited by 23
Yonezawa, K., Tani, H., Nakajima, S., Nagai, N., Koizumi, T., Miyazaki, T., Mimura, M., Takahashi, T., & Uchida, H. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.033 · Cited by 23
Chamberlain, S. E. L., Jane, D. E., & Jones, R. S. G. (2011) · Hippocampus · doi:10.1002/hipo.20921 · Cited by 23
Phillips, A. G., Geyer, M. A., & Robbins, T. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.014 · Cited by 22
Andronis, C., Silva, J. P., Lekka, E., Virvilis, V., Carmo, H., Bampali, K., Ernst, M. C., Hu, Y., Loryan, I., Richard, J., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02788-1 · Cited by 22
Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia
Hammond, J. C., McCullumsmith, R. E., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.029 · Cited by 22
Self-citationMenke, A., Sämann, P. G., Kloiber, S. M., Czamara, D., Lucae, S., Hennings, J. M., Heck, A., Kohli, M. A., Czisch, M., Müller‐Myhsok, B., et al. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.003 · Cited by 23
Bitanihirwe, B. K., Lim, M. P., & Woo, T. W. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00785.x · Cited by 21
Song, D., Li, B., Yan, E., Man, Y., Wolfson, M., Chen, Y., & Peng, L. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0837-7 · Cited by 21
Ketamine, benzoate, and sarcosine for treating depression
Cheng, Y., Lin, C., & Lane, H. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109351 · Cited by 21
Freudenberg, F., Marx, V., Mack, V., Layer, L. E., Klugmann, M., Seeburg, P. H., Sprengel, R., & Celikel, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.003 · Cited by 21
Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction
Mennesson, M., Rydgren, E., Lipina, T. V., Sokolowska, E., Kulesskaya, N., Morello, F., Ivakine, E. A., Võikar, V., Risbrough, V. B., Partanen, J. M., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0344-5 · Cited by 20
Wu, X., Shukla, R., Alganem, K., Zhang, X., Eby, H., Devine, E. A., DePasquale, E. A. K., Reigle, J. K., Simmons, M. S., Hahn, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01205-y · Cited by 20
Self-citationContributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia
Krystal, J. H., & Moghaddam, B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch21 · Cited by 20
Fan, Z., Qian, Y., Lu, Q., Wang, Y., Chang, S., & Yang, L. (2018) · Brain and Behavior · doi:10.1002/brb3.914 · Cited by 20
Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function
Duncan, G. E., Inada, K., Koller, B. H., & Moy, S. S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.023 · Cited by 20
Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants
Verkhratsky, A., Parpura, V., Scuderi, C., & Li, B. (2021) · Advances in Neurobiology · doi:10.1007/978-3-030-77375-5_13 · Cited by 19
Flynn, L. T., & Gao, W. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02235-4 · Cited by 19
Bao, H., Ran, P., Zhu, M., Sun, L., Li, B., Hou, Y., Nie, J., Shan, L., Li, H., Zheng, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28395 · Cited by 19
Intracellular Signaling Cascades in Bipolar Disorder
Jones, G. H., Rong, C., Shariq, A. S., Mishra, A. P., & Machado‐Vieira, R. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_157 · Cited by 19
Zhou, L., Wang, H., Gu, J., & Gao, F. (2022) · Synapse · doi:10.1002/syn.22247 · Cited by 19
Piyabhan, P., Wannasiri, S., & Naowaboot, J. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12658 · Cited by 19
Yoshimi, A., Takahashi, N., Saito, S., Ito, Y., Aleksić, B., Usui, H., Kawamura, Y., Waki, Y., Yoshikawa, T., Kato, T., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.028 · Cited by 19
A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia
Büki, A., Kékesi, G., Horváth, G., & Vécsei, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810016 · Cited by 18
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
Kowalczyk, M., Kowalczyk, E., Kwiatkowski, P. A., Łopusiewicz, Ł., Sienkiewicz, M., & Talarowska, M. E. (2021) · Life · doi:10.3390/life11111186 · Cited by 18
Hasegawa, S., Yoshimi, A., Mouri, A., Uchida, Y., Hida, H., Mishina, M., Yamada, K., Ozaki, N., Nabeshima, T., & Noda, Y. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.020 · Cited by 18
The associations of zinc and GRIN2B genetic polymorphisms with the risk of dyslexia
Liu, Q., Zhu, B. Y., Xue, Q., Xie, X., Zhou, Y., Zhu, K., Wan, Z., Wu, H., Zhang, J., & Song, R. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110207 · Cited by 18
A possible key role of vision in the development of schizophrenia
Császár, N., Kapócs, G., & Bókkon, I. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0022 · Cited by 18
Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets
Panek, M., Kawalec, P., Malinowska‐Lipień, I., Brzostek, T., & Pilc, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1836160 · Cited by 17
Guglielmo, R., & Hasler, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104906 · Cited by 18
Glessner, J., Khan, M. E., Chang, X., Liu, Y., Otieno, F. G., Lemma, M., Slaby, I., Hain, H. S., Mentch, F. D., Li, J., et al. (2023) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-023-09483-z · Cited by 17
Lillethorup, T. P., Iversen, P., Wegener, G., Doudet, D. J., & Landau, A. M. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.24 · Cited by 17
Crosstalk between neurokinin receptor signaling and neuroinflammation in neurological disorders
Eapen, P., Rao, C. M., & Nampoothiri, M. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0021 · Cited by 17
Pinacho, R., Saia, G., Meana, J. J., Gill, G., & Ramos, B. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.05.006 · Cited by 17
Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders
Popoli, M., Diamond, D., & Sanacora, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4 · Cited by 18
Biological Psychiatry and Psychopharmacology
Fountoulakis, K. N., Nimatoudis, I., & Stahl, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-18323-3_13 · Cited by 17
Yates, J. R. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111107 · Cited by 16
Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders
Onisiforou, A., Michael, A., Apostolakis, M., Mammadov, E., Mitka, A., Kalatta, M. A., Koumas, M., Georgiou, A. N., Chatzittofis, A., Panayiotou, G., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.008 · Cited by 16
Microarray analysis of gene expression changes in the brains of NR2B-induced memory-enhanced mice
Li, C., Dong, S., Wang, H., & Hu, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.031 · Cited by 17
Ferreira, N. R., Vitorino, C., & Fortuna, A. C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115300 · Cited by 16
Yonezawa, K., Uchida, H., Yatomi, T., Ohtani, Y., Nomoto‐Takahashi, K., Nakajima, S., Mimura, M., & Tani, H. (2023) · Pharmacopsychiatry · doi:10.1055/a-2179-8884 · Cited by 16
Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression
Freudenberg, F., Reif-Leonhard, C., & Reif, A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01875-z · Cited by 15
Carrier, M., Hui, C. W., Watters, V., Šimončičová, E., Picard, K., Ibáñez, F. G., Vernoux, N., Droit, A., Desjardins, M., & Tremblay, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.025 · Cited by 15
Glutamate receptor subunit expression in the rhesus macaque locus coeruleus
Noriega, N. C., Garyfallou, V. T., Kohama, S. G., & Urbanski, H. F. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.007 · Cited by 15
A 12p13 GRIN2B deletion is associated with developmental delay and macrocephaly
Morisada, N., Ioroi, T., Taniguchi‐Ikeda, M., Ye, M. J., Okamoto, N., Yamamoto, T., & Iijima, K. (2016) · Human Genome Variation · doi:10.1038/hgv.2016.29 · Cited by 15
Targeting the dysfunction of glutamate receptors for the development of novel antidepressants
Xia, C., He, J., Du, L., Yan, Y., Lian, W., Xu, J., & Zhang, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107875 · Cited by 15
Chen, M., Jin, J., Bi, H., Zhang, Y., Sun, M., Li, X., & Wang, Y. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104502 · Cited by 14
Mishra, N., Pulcine, E., Orsino, A., & Minassian, B. A. (2016) · Child Neurology Open · doi:10.1177/2329048x16629980 · Cited by 14
Skiteva, O., Yao, N., & Chergui, K. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01658-3 · Cited by 13
Filho, A. J. M. C., Mottin, M., Lós, D. B., Andrade, C. H., & Macêdo, D. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.07.015 · Cited by 13
Hu, T., Wu, C., Hsu, S.-H., Tsai, H.-Y., Cheng, F.-Y., & Cheng, M.-C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050783 · Cited by 13
Piyabhan, P., & Wetchateng, T. (2013) · PubMed · Cited by 13
GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia
Geddes, A. E., Huang, X., & Newell, K. A. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0274-z · Cited by 13
Schroeder, E. K., Gao, Y., Lei, Z. M., Roisen, F. J., & El‐Mallakh, R. S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.018 · Cited by 13
Hoeller, A. A., Costa, A. P., Bicca, M. A., MATHEUS, F. C., Lach, G., Spiga, F., Lightman, S. L., Walz, R., Collingridge, G. L., Bortolotto, Z. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147293 · Cited by 13
Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse
Hrabovská, A., Farár, V., Bernard, V., Duysen, E. G., Brabec, J., Lockridge, O., & Mysliveček, J. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.09.025 · Cited by 13
Wang, Z. Q., Wang, X., Mou, X., Wang, C., Sun, Y., & Wang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1471307 · Cited by 13
Ho, C. S. H., Soh, M. W. T., & Tay, G. W. N. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152363 · Cited by 12
Cao, P., Chen, C., Si, Q., Li, Y., Ren, F., Han, C., Zhao, J., Wang, X., Xu, G., & Sui, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1191170 · Cited by 12
Structural basis of GluK2 kainate receptor activation by a partial agonist
Segura-Covarrubias, G., Zhou, C., Bogdanović, N., Zhang, L., & Tajima, N. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01566-w · Cited by 12
Millard, S. J., Lum, J. S., Fernandez, F., Weston–Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110174 · Cited by 12
Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits
Zhang, M., Kong, X., Chen, J., Liu, W., Liu, C., Dou, X., Jiang, L. H., Luo, Y., Song, M., Miao, P., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.076 · Cited by 11
Tang, Q., Chu, H., Sun, N., Fan, X., Han, B., Li, Y. X., Yu, X. L., Li, L., Wang, X., Liu, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119268 · Cited by 11
NMDA Antagonists and Their Role in the Management of Bipolar Disorder: a Review
Delfino, R. S., Surjan, J. C., Bandeira, I. D., Braziliano, L., Correia‐Melo, F. S., Del-Porto, J. A., Quarantini, L. C., & Lacerda, A. L. T. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00201-w · Cited by 11
Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice
Boer, S., Sánchez, D., Reinieren, I., van den Boom, T., Udawela, M., Scarr, E., Ganfornina, M. D., & Dean, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.016 · Cited by 11
Case–control association study ofGRIA1,GRIA2andGRIA4polymorphisms in bipolar disorder
Chiesa, A., Crisafulli, C., Porcelli, S., Balzarro, B., Han, C., Patkar, A. A., Lee, S.-J., Park, M. H., Pae, C.-U., & Serretti, A. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.617459 · Cited by 11
Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse
Kerner, B. (2009) · The Open Psychiatry Journal · doi:10.2174/1874354400903010001 · Cited by 10
Metadata
- Authors
- Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-14
- Volume
- 32
- Issue
- 9
- Pages
- 1888-1902
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2024278554
- Cited by
- 408
- References
- 115
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 32 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 10 · 2017: 13 · 2016: 18 · 2015: 32 · 2014: 23 · 2013: 25 · 2012: 28
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- National Institute of Mental Health (MH 53327, R01MH053327)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- glutamate receptors, schizophrenia, bipolar disorder, major depressive disorder, mood disorders, medial temporal lobe, entorhinal cortex, perirhinal cortex, hippocampus, NMDA receptor, AMPA receptors, kainate receptors, receptor binding, glutamatergic neurotransmission, synaptic transmission
- MeSH terms
- Adult, Analysis of Variance, Autoradiography, Female, Gene Expression Regulation, Humans, Indoles, Male, Middle Aged, Postmortem Changes, Protein Binding, Schizophrenia, Temporal Lobe, 2-Amino-5-phosphonovalerate, In Situ Hybridization, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.